China Re Sets 26 Jun 2026 AGM to Approve 2025 Results, Dividend and Rolling Capital Plan

Bulletin Express
06/04

China Reinsurance (Group) Corporation will convene its 2025 Annual Shareholders’ Meeting on 26 June 2026 at 9:30 a.m. in Beijing. The on-site meeting will be held on the 6th and 24th floors of China Re Building, No. 11 Jinrong Avenue, Xicheng District.

Key ordinary resolutions: • Elect Mr. Zhang Xueyong as an independent non-executive director for the fifth board session. • Approve the Board of Directors’ 2025 report, final financial accounts and 2025 profit-distribution plan. • Endorse the 2026 fixed-asset investment budget and the three-year rolling capital plan for 2026-2028. • Confirm the appointment and remuneration of statutory financial-reporting auditors for 2026.

Special resolution: approve external donations for 2026.

Shareholders will also review (without voting) directors’ and independent directors’ 2025 performance reports, the evaluation of directors and supervisors, the overall related-party transaction report, solvency analysis for 2025 and the 2026-2027 renewal arrangements for liability insurance covering directors, supervisors and senior management.

Share-transfer details: • Attendance and voting entitlement: the register of members closes from 23 June 2026 to 26 June 2026 (both days inclusive); record date is 26 June 2026. • Dividend entitlement: the register closes from 3 July 2026 to 8 July 2026; shareholders on record as of 8 July 2026 qualify for the 2025 final dividend, subject to shareholder approval.

Proxies must be lodged with Computershare Hong Kong Investor Services no later than 9:30 a.m. on 25 June 2026. All meeting resolutions will be decided by poll, and results will be published on the websites of China Re and HKEx.

The meeting is expected to last half a day; attendees are responsible for their own travel and accommodation costs. As at the notice date (5 June 2026), the Board comprises two executive directors, three non-executive directors and three independent non-executive directors.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10